[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11202012198QA - Engineered phenylalanine ammonia lyase polypeptides - Google Patents

Engineered phenylalanine ammonia lyase polypeptides

Info

Publication number
SG11202012198QA
SG11202012198QA SG11202012198QA SG11202012198QA SG11202012198QA SG 11202012198Q A SG11202012198Q A SG 11202012198QA SG 11202012198Q A SG11202012198Q A SG 11202012198QA SG 11202012198Q A SG11202012198Q A SG 11202012198QA SG 11202012198Q A SG11202012198Q A SG 11202012198QA
Authority
SG
Singapore
Prior art keywords
ammonia lyase
phenylalanine ammonia
engineered phenylalanine
lyase polypeptides
polypeptides
Prior art date
Application number
SG11202012198QA
Other languages
English (en)
Inventor
Scott Novick
Ravi Garcia
Charlene Ching
Nikki Dellas
David Entwistle
Vesna Mitchell
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of SG11202012198QA publication Critical patent/SG11202012198QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y403/00—Carbon-nitrogen lyases (4.3)
    • C12Y403/01—Ammonia-lyases (4.3.1)
    • C12Y403/01024—Phenylalanine ammonia-lyase (4.3.1.24)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0022—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202012198QA 2018-07-12 2019-06-14 Engineered phenylalanine ammonia lyase polypeptides SG11202012198QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862696978P 2018-07-12 2018-07-12
US201962814362P 2019-03-06 2019-03-06
PCT/US2019/037205 WO2020013951A1 (en) 2018-07-12 2019-06-14 Engineered phenylalanine ammonia lyase polypeptides

Publications (1)

Publication Number Publication Date
SG11202012198QA true SG11202012198QA (en) 2021-01-28

Family

ID=69140030

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012198QA SG11202012198QA (en) 2018-07-12 2019-06-14 Engineered phenylalanine ammonia lyase polypeptides

Country Status (8)

Country Link
US (2) US11198861B2 (de)
EP (1) EP3820833A4 (de)
JP (1) JP2021531749A (de)
CN (1) CN112672989A (de)
CA (1) CA3105916A1 (de)
IL (1) IL279916A (de)
SG (1) SG11202012198QA (de)
WO (1) WO2020013951A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL295353A (en) 2020-03-20 2022-10-01 Synlogic Operating Co Inc Genetically engineered microorganisms to reduce hyperphenylalaninemia
WO2022145178A1 (ja) * 2020-12-28 2022-07-07 国立研究開発法人理化学研究所 フェニルアラニンアンモニアリアーゼを用いた鎖状の不飽和カルボン酸化合物の製造方法
WO2023039466A1 (en) * 2021-09-08 2023-03-16 Ginkgo Bioworks, Inc. Engineered phenylalanine ammonia lyase enzymes
US20230383535A1 (en) * 2022-05-26 2023-11-30 Green Canopy NODE Technologies, INC Modular wall component and a method for manufacturing a modular wall component
CN117417925A (zh) * 2022-07-18 2024-01-19 浙江泽科塔生物医药有限公司 Pal变体、包含该pal变体的药物组合物以及用于制备该pal变体的方法
WO2024032012A1 (zh) * 2022-08-10 2024-02-15 百葵锐(深圳)生物科技有限公司 苯丙氨酸解氨酶突变体及其应用

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246943A (en) 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
BR9507817A (pt) 1994-06-03 1997-09-16 Novo Nordisk Biotech Inc Construção de dna enzima vetor recombinante célula hospedeira recombinante lacase de ascomicete ou deuteromicete processos para obter uma enzima de lacase para melhorar o rendimento de enzima recombinante para polimerizar um substrato de lignina ou lignossulfato em soluç o para despolimerizar in situ a pasta kraft para oxidar corantes ou precursores de corantes para pintar cabelo e para polimerizar ou oxidar um composto fenólico ou anilina composição de corante e recipiente contendo a mesma
WO1996000787A1 (en) 1994-06-30 1996-01-11 Novo Nordisk Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
ATE334225T1 (de) 1997-01-17 2006-08-15 Maxygen Inc Evolution prokaryotischer ganzer zellen durch rekursive sequenzrekombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
WO1998031816A1 (en) 1997-01-17 1998-07-23 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
EP2270234B1 (de) 1997-12-08 2013-03-06 California Institute of Technology Verfahren zur Erzeugung von Polynukleotid- und Polypeptidsequenzen
JP2002510506A (ja) 1998-04-02 2002-04-09 テラス ジェネティック リソーシズ，インコーポレイティド 遺伝子配列に遺伝障害を有する植物を得る方法
BR9910174A (pt) 1998-05-01 2001-03-06 Maxygen Inc Processo para se obter um gene recombinante otimizado de resistência à praga, biblioteca, e, processo para se obter um organismo que seja patogênico a uma praga de vegetal
EP1090024A2 (de) 1998-06-17 2001-04-11 Maxygen, Inc. Methode für die herstellung von polynukleotiden mit gewünschten eigenschaften
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
US6605430B1 (en) 1998-08-12 2003-08-12 Maxygen, Inc. DNA shuffling of monooxygenase genes for production of industrial chemicals
EP1119616A2 (de) 1998-10-07 2001-08-01 Maxygen, Inc. Dna shuffling zur herstellung von nukleinsäuren zur mykotoxinentgiftung
WO2000028018A1 (en) 1998-11-10 2000-05-18 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
EP1108783A3 (de) 1999-01-19 2001-09-05 Maxygen, Inc. Oligonukletiden-gesteuerte Nukleinsäurerekombination
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
KR20010102069A (ko) 1999-02-11 2001-11-15 추후제출 고효율 질량 분석
WO2000052155A2 (en) 1999-03-05 2000-09-08 Maxygen, Inc. Recombination of insertion modified nucleic acids
US6703240B1 (en) 1999-04-13 2004-03-09 Maxygar, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
US6686515B1 (en) 1999-11-23 2004-02-03 Maxygen, Inc. Homologous recombination in plants
AU2788101A (en) 2000-01-11 2001-07-24 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
WO2001075767A2 (en) 2000-03-30 2001-10-11 Maxygen, Inc. In silico cross-over site selection
DE60144145D1 (de) 2000-04-03 2011-04-14 Maxygen Inc Subtilisin-variante
US6967097B2 (en) * 2000-07-24 2005-11-22 Pcbu Services, Inc. Phenylalainine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
ES2564570T3 (es) 2002-03-01 2016-03-23 Codexis Mayflower Holdings, Llc Métodos, sistemas y software para la identificación de biomoléculas funcionales
WO2003078583A2 (en) 2002-03-09 2003-09-25 Maxygen, Inc. Optimization of crossover points for directed evolution
CA2580679A1 (en) 2004-09-17 2006-03-30 Biomarin Pharmaceutical Inc. Variants and chemically-modified variants of phenylalanine ammonia-lyase
JP2008525515A (ja) * 2004-12-28 2008-07-17 ディーエスエム アイピー アセッツ ビー．ブイ． 光学活性なインドリン−２−カルボン酸の調製方法
ES2383767T3 (es) * 2006-03-07 2012-06-26 Verenium Corporation Aldolasas, ácidos nucleicos que las codifican y métodos para producir y usar las mismas
EP2029739A4 (de) * 2006-06-02 2009-11-25 Verenium Corp Lyase-enzyme, nukleinsäuren zu deren kodierung und verfahren zu deren herstellung und verwendung
US7534595B2 (en) * 2006-06-12 2009-05-19 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
JP5563990B2 (ja) * 2008-01-03 2014-07-30 ヴェレニウム コーポレイション トランスフェラーゼおよびオキシドレダクターゼ、それらをコードする核酸並びにそれらを製造および使用する方法
EP2250595B1 (de) 2008-02-12 2017-06-14 Codexis, Inc. Verfahren zum erzeugen einer optimierten diversen population von varianten
US8768871B2 (en) 2008-02-12 2014-07-01 Codexis, Inc. Method of generating an optimized, diverse population of variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
DK2285958T3 (en) 2008-06-13 2016-03-29 Codexis Inc Method for synthesizing polynucleotides
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
WO2012010843A1 (en) * 2010-07-21 2012-01-26 Spinifex Pharmaceuticals Pty Ltd Salt and solvates of a tetrahydroisoquinoline derivative
HUE042817T2 (hu) 2011-06-28 2019-07-29 Codexis Inc Fehérjevariánsok elõállítása régiókeveréssel
US20150133698A1 (en) 2012-04-20 2015-05-14 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
ES2890955T3 (es) 2013-04-18 2022-01-25 Codexis Inc Polipéptidos de fenilalanina amoníaco liasa modificados
CN106459935A (zh) * 2014-03-27 2017-02-22 诺维信公司 具有磷脂酶c活性的多肽和编码它们的多核苷酸

Also Published As

Publication number Publication date
CA3105916A1 (en) 2020-01-16
EP3820833A1 (de) 2021-05-19
WO2020013951A1 (en) 2020-01-16
US20200017845A1 (en) 2020-01-16
IL279916A (en) 2021-03-01
JP2021531749A (ja) 2021-11-25
CN112672989A (zh) 2021-04-16
US20220056431A1 (en) 2022-02-24
US11198861B2 (en) 2021-12-14
EP3820833A4 (de) 2022-08-03

Similar Documents

Publication Publication Date Title
IL279916A (en) Transgenic phenylalanine ammonia lyase polypeptides
IL242067B (en) Transgenic phenylalanine ammonia lyase polypeptides
IL275298B1 (en) Mitochondria-targeted peptides
IL271114A (en) Transaminase engineered polypeptides for industrial biocatalysis
HK1254601A1 (zh) 新型肽
IL283803A (en) binds peptides
SG11202005653RA (en) Novel peptide
IL268226A (en) Phenylalanine ammonia lyase engineered polypeptides
GB201700557D0 (en) Novel peptides
HUE056444T2 (hu) Génmódosított tirozin-ammónia-liáz
IL283894A (en) An engineered tyrosine ammonia lyase
EP3807409A4 (de) Manipulierte tyrosin-ammoniak-lyase
GB2584210B (en) Peptides for inhibiting RAD51
IL284588A (en) Transaminase polypeptides are engineered
IL282676A (en) New dipeptide compounds and their uses
GB201814440D0 (en) Peptide
GB201803074D0 (en) Peptide
GB201815548D0 (en) Improved clip
GB201719520D0 (en) Neuroprotectvie peptide
GB201805801D0 (en) Peptides
GB201805807D0 (en) Peptides
GB201805809D0 (en) Peptides
GB201715378D0 (en) Peptides
GB201715379D0 (en) Peptides
GB201711620D0 (en) Peptides